cbdMD, Inc. (YCBD)

Market Cap	1.74M
Revenue (ttm)	20.64M
Net Income (ttm)	-23.42M
Shares Out	3.84M
EPS (ttm)	-8.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,230
Open	0.450
Previous Close	0.450
Day's Range	0.425 - 0.470
52-Week Range	0.420 - 1.730
Beta	1.99
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 20, 2024

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distri...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 52
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD
• Website: https://www.cbdmd.com

Financial Performance

In 2023, cbdMD's revenue was $24.16 million, a decrease of -31.77% compared to the previous year's $35.40 million. Losses were -$26.94 million, -63.64% less than in 2022.